应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GTHX G1 Therapeutics Inc.
停牌 09-17 16:00:00 EDT
7.15
+0.00
0.00%
最高
7.15
最低
7.15
成交量
0.00
今开
7.15
昨收
7.15
日振幅
0.00%
总市值
3.78亿
流通市值
2.81亿
总股本
5,289万
成交额
905.67万
换手率
0.00%
流通股本
3,925万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
G1 Therapeutics, Inc.2024财年第二财季实现净利润-5.47百万美元,同比减少162.80%
自选股智能写手 · 08-18
G1 Therapeutics, Inc.2024财年第二财季实现净利润-5.47百万美元,同比减少162.80%
BUZZ--美国股票走势-雅培实验室、美敦力、Axon
Reuters · 08-08
BUZZ--美国股票走势-雅培实验室、美敦力、Axon
G1 Therapeutics, Inc.股价飙升66.35% 市值涨2.45亿美元
自选股智能写手 · 08-07
G1 Therapeutics, Inc.股价飙升66.35% 市值涨2.45亿美元
BUZZ--美国股票走势-华特迪士尼、SpringWorks、Shopify
Reuters · 08-07
BUZZ--美国股票走势-华特迪士尼、SpringWorks、Shopify
BUZZ-G1 Therapeutics 从 Pharmacosmos 4.05 亿美元收购后一跃而起
Reuters · 08-07
BUZZ-G1 Therapeutics 从 Pharmacosmos 4.05 亿美元收购后一跃而起
G1 Therapeutics, Inc.盘中异动 股价大跌9.80%报3.59美元
自选股智能写手 · 08-05
G1 Therapeutics, Inc.盘中异动 股价大跌9.80%报3.59美元
G1 Therapeutics, Inc.盘中异动 早盘股价大涨5.78%
自选股智能写手 · 06-27
G1 Therapeutics, Inc.盘中异动 早盘股价大涨5.78%
G1 Therapeutics, Inc.盘中异动 早盘股价大跌8.11%
自选股智能写手 · 06-25
G1 Therapeutics, Inc.盘中异动 早盘股价大跌8.11%
G1 Therapeutics, Inc.盘中异动 股价大跌33.48%报1.65美元
自选股智能写手 · 06-24
G1 Therapeutics, Inc.盘中异动 股价大跌33.48%报1.65美元
更新版 1-G1 Therapeutics 公司的乳腺癌药物在晚期试验中失败
Reuters · 06-24
更新版 1-G1 Therapeutics 公司的乳腺癌药物在晚期试验中失败
BUZZ-G1 Therapeutics 因乳腺癌药物未能达到主要研究目标而下跌
Reuters · 06-24
BUZZ-G1 Therapeutics 因乳腺癌药物未能达到主要研究目标而下跌
G1 Therapeutics 的乳腺癌疗法未能通过后期试验
Reuters · 06-24
G1 Therapeutics 的乳腺癌疗法未能通过后期试验
G1 Therapeutics, Inc.盘中异动 急速上涨5.14%
自选股智能写手 · 06-14
G1 Therapeutics, Inc.盘中异动 急速上涨5.14%
G1 Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报3.23美元
自选股智能写手 · 05-30
G1 Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报3.23美元
HC Wainwright & Co.:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。
智通财经 · 05-29
HC Wainwright & Co.:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。
Needham:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.
智通财经 · 05-28
Needham:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.
G1 Therapeutics, Inc.盘中异动 急速下跌5.38%报3.87美元
自选股智能写手 · 05-28
G1 Therapeutics, Inc.盘中异动 急速下跌5.38%报3.87美元
G1 Therapeutics, Inc.盘中异动 早盘急速上涨5.08%
自选股智能写手 · 05-22
G1 Therapeutics, Inc.盘中异动 早盘急速上涨5.08%
BUZZ-G1 Therapeutics 因达成放射保护药物许可协议而攀升
Reuters · 05-22
BUZZ-G1 Therapeutics 因达成放射保护药物许可协议而攀升
G1 Therapeutics-预计将在全面摊薄的基础上获得占Deimos已发行股本10%的Deimos普通股
智通财经 · 05-22
G1 Therapeutics-预计将在全面摊薄的基础上获得占Deimos已发行股本10%的Deimos普通股
暂无数据
公司概况
公司名称:
G1 Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
G1 Therapeutics, Inc.于2008年5月19日以“G-Zero Therapeutics, Inc.”的名义,以特拉华州的法律注册成立。2012年9月,他们更名为“G1治疗公司”。该公司是一家商业化阶段的生物制药公司,专注于开发和商业化治疗癌症患者的新型小分子疗法。美国食品和药物管理局批准的第一个产品COSELA(trilaciclib)是第一个也是唯一一个被证明可以主动帮助保护骨髓免受化疗(骨髓保护)损害的疗法,也是几十年来管理骨髓保护的第一个创新。2022年7月,COSELA(注射用盐酸曲拉西利布)获国家药品监督管理局有条件批准在中国上市。
发行价格:
--
{"stockData":{"symbol":"GTHX","market":"US","secType":"STK","nameCN":"G1 Therapeutics Inc.","latestPrice":7.15,"timestamp":1726603200000,"preClose":7.15,"halted":3,"volume":0,"delay":0,"floatShares":39251364,"shares":52890375,"eps":-0.859862,"marketStatus":"停牌","marketStatusCode":7,"change":0,"latestTime":"09-17 16:00:00 EDT","open":7.15,"high":7.15,"low":7.15,"amount":9056687.850192,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.859862,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1494993600000,"adjPreClose":7.15,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/GTHX/tweets","defaultTab":"tweets","newsList":[{"id":"2460735765","title":"G1 Therapeutics, Inc.2024财年第二财季实现净利润-5.47百万美元,同比减少162.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460735765","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460735765?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:00","pubTimestamp":1723910422,"startTime":"0","endTime":"0","summary":"8月18日,G1 Therapeutics, Inc.公布财报,公告显示公司2024财年第二财季净利润为-5.47百万美元,同比减少162.80%;其中营业收入为16.55百万美元,同比减少60.96%,每股基本收益为-0.10美元。从资产负债表来看,G1 Therapeutics, Inc.总负债74.10百万美元,其中短期债务11.41百万美元,资产负债比为1.34,流动比率为2.48。机构评级:截至2024年8月18日,当前有3家机构对G1 Therapeutics, Inc.目标价做出预测,其中目标均价为7.15美元,其中最低目标价为7.15美元,最高目标价为7.15美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800003395a162de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800003395a162de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","LENZ"],"gpt_icon":0},{"id":"2457875841","title":"BUZZ--美国股票走势-雅培实验室、美敦力、Axon","url":"https://stock-news.laohu8.com/highlight/detail?id=2457875841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457875841?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:47","pubTimestamp":1723056454,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 8月7日 - 华尔街主要股指周三上扬,受助于大型股的上涨,以及日本最高决策者在上周意外加息后转为鸽派,这在一定程度上引发了全球市场的剧烈波动。美东时间14:35 ,道琼斯工业平均指数 下跌0.52%,报38,793.6 点。标普500指数 下跌0.53%,报5,212.5点;纳斯达克综合指数 下跌0.77%,报16,240.061点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NYT","LYFT","APA","INSP","XOM","UDOW","SDOW","PODD","GTHX",".IXIC",".DJI","REAL","DXD",".SPX","NEXT","CVX","QID","DJX","TSVT","PGNY","DDM","NQmain","BUZZ","BKR","OSCR","ROK","SWTX","TECH","CART","SMCI","ILMN","ABT","MDT","VCYT","IEP","PSQ","DXCM","EMR","CYRX","PETQ","AXON","CRL","TNDM","DIS","AMGN"],"gpt_icon":1},{"id":"2457411288","title":"G1 Therapeutics, Inc.股价飙升66.35% 市值涨2.45亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457411288","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457411288?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:33","pubTimestamp":1723037585,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时33分,G1 Therapeutics, Inc.股票出现异动,股价大幅拉升66.35%。截至发稿,该股报7.07美元/股,成交量1281.04万股,换手率24.50%,振幅0.47%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.72%。其相关个股中,G1 Therapeutics, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Windtree Therapeutics, Inc.涨幅较大,Scorpius Holdings, Inc.、Aditxt, Inc.、Silo Pharma, Inc.较为活跃,换手率分别为265.57%、167.04%、42.45%,振幅较大的相关个股有Aditxt, Inc.、Neurosense Therapeutics Ltd.、天境生物,振幅分别为28.97%、14.49%、12.26%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133059f17752c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133059f17752c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GTHX"],"gpt_icon":0},{"id":"2457810966","title":"BUZZ--美国股票走势-华特迪士尼、SpringWorks、Shopify","url":"https://stock-news.laohu8.com/highlight/detail?id=2457810966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457810966?lang=zh_cn&edition=full","pubTime":"2024-08-07 20:10","pubTimestamp":1723032604,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 8月7日 - 美国股指期货周三跳涨,原因是风险偏好在本周早些时候大幅下挫后有所恢复,一位有影响力的日本央行决策者对加息的谨慎评论也提振了市场情绪。美东时间7:59,道指电子盘 上涨0.86%,报39,478 点。标普500指数小型股 上涨1.02%,报5319.75点;纳斯达克100指数小型股 上涨1.14%,报18385.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4560","IE0002141913.USD","LU1571399168.USD","IE00B19Z9Z06.USD","LU0708994859.HKD","BK4108","CVS","GB00BDT5M118.USD","LU0208291251.USD","GTHX","UPST","TRIP","LU0029864427.USD","DIS","LU0122379950.USD","LU1061106388.HKD","BK4585","SWTX","BK4154","SHOP","LYFT","HLT","SG9999015952.SGD","BK4144","LU0011850046.USD","AMGN","IE00B4R5TH58.HKD","LU0823411888.USD","BK4551","LU0128525929.USD","EBS","LU0320765489.SGD","SG9999015986.USD","LU0061475181.USD","BK4554","BK4142","BK4532","FTNT","NEXT","BK4561","LU0058720904.USD","SG9999015945.SGD","LU0868494617.USD","BK4524","LU2023250843.SGD","LU2106854487.HKD","LU2286300806.USD","PGNY","BK4230","BUZZ"],"gpt_icon":1},{"id":"2457681169","title":"BUZZ-G1 Therapeutics 从 Pharmacosmos 4.05 亿美元收购后一跃而起","url":"https://stock-news.laohu8.com/highlight/detail?id=2457681169","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457681169?lang=zh_cn&edition=full","pubTime":"2024-08-07 19:12","pubTimestamp":1723029165,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 8月7日 - ** G1 Therapeutics 股价盘前大涨~64%至6.95美元 ** 丹麦 Pharmacosmos 公司将以约 4.05 亿美元现金收购该公司 ** Pharmacosmos 的报价为每股 7.15 美元,比 GTHX 的前收盘价溢价 68 ** 交易将把 GTHX 的药物 Cosela 加入 Pharmacosmo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BUZZ","GTHX"],"gpt_icon":0},{"id":"2457377517","title":"G1 Therapeutics, Inc.盘中异动 股价大跌9.80%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457377517","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457377517?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:40","pubTimestamp":1722865230,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时40分,G1 Therapeutics, Inc.股票出现异动,股价急速下跌9.80%。截至发稿,该股报3.59美元/股,成交量6.3813万股,换手率0.12%,振幅2.76%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.18%。其相关个股中,Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Cervomed Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃,换手率分别为1090.04%、53.99%、14.18%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Alterity Therapeutics Limited、60 Degrees Pharmaceuticals, Inc.,振幅分别为21.59%、20.00%、17.81%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214030957f3395&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214030957f3395&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTHX","LENZ"],"gpt_icon":0},{"id":"2446558943","title":"G1 Therapeutics, Inc.盘中异动 早盘股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446558943","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446558943?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:35","pubTimestamp":1719495323,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时35分,G1 Therapeutics, Inc.股票出现波动,股价快速上涨5.78%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。消息层面,截至21时35分,《TD Cowen维持G1 Therapeutics买入评级》资讯为影响G1 Therapeutics, Inc.的重要信息。该信息摘要如下:TD Cowen分析师Joseph Thome维持$G1 Therapeutics $买入评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721352396817824&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721352396817824&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTHX","LENZ"],"gpt_icon":0},{"id":"2446849755","title":"G1 Therapeutics, Inc.盘中异动 早盘股价大跌8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446849755","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446849755?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:39","pubTimestamp":1719322768,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时39分,G1 Therapeutics, Inc.股票出现波动,股价大幅下跌8.11%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。其相关个股中,Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大,Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为99.32%、88.15%、63.92%,振幅较大的相关个股有Cingulate Inc.、Werewolf Therapeutics, Inc.、Glycomimetics, Inc.,振幅分别为19.77%、16.85%、15.94%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213928af8f2079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213928af8f2079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTHX","LENZ"],"gpt_icon":0},{"id":"2445072747","title":"G1 Therapeutics, Inc.盘中异动 股价大跌33.48%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072747","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445072747?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:32","pubTimestamp":1719235930,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时32分,G1 Therapeutics, Inc.股票出现异动,股价大幅下跌33.48%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences, Inc.、阿里拉姆制药涨幅较大,Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃,换手率分别为336.94%、43.78%、33.44%,振幅较大的相关个股有Revelation Biosciences, Inc.、Psyence Biomedical Ltd.、G1 Therapeutics, Inc.,振幅分别为23.70%、11.62%、10.20%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421321095d2b57f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421321095d2b57f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2445027534","title":"更新版 1-G1 Therapeutics 公司的乳腺癌药物在晚期试验中失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2445027534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445027534?lang=zh_cn&edition=full","pubTime":"2024-06-24 19:11","pubTimestamp":1719227494,"startTime":"0","endTime":"0","summary":" 路透6月24日 - G1 Therapeutics 周一表示,其治疗 一种罕见的侵袭性乳腺癌 的药物 在一项晚期试验中没有达到总生存期的主要目标。G1公司的药物trilaciclib在187名转移性三阴性乳腺癌患者中进行了试验,服药患者的中位总生存期为17.4个月,而未接受治疗的患者的总生存期为17.8个月。首席执行官杰克-贝利说,G1 公司将评估 trilaciclib 的其他用途,并将寻求 合作伙伴在全球范围内扩大其使用范围。G1 therapeutics公司的股票在盘前交易中下跌了31.8% 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2445022654","title":"BUZZ-G1 Therapeutics 因乳腺癌药物未能达到主要研究目标而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2445022654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445022654?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:59","pubTimestamp":1719226782,"startTime":"0","endTime":"0","summary":" 6月24日 - ** G1 Therapeutics 股价在盘前交易中下跌18.1%,至2.03美元 ** 该公司的药物trilaciclib未能达到一项晚期研究的主要目标,该研究针对的是一种会扩散到身体其他部位的乳腺癌患者。** 截至上次收盘,GHTX 年累计下跌约 19","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTHX","LENZ","BUZZ"],"gpt_icon":0},{"id":"2445302480","title":"G1 Therapeutics 的乳腺癌疗法未能通过后期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2445302480","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445302480?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:36","pubTimestamp":1719225408,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月24日 - G1 Therapeutics 周一表示,其治疗一种乳腺癌的疗法在一项晚期试验中没有达到总生存期的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTHX","LENZ"],"gpt_icon":0},{"id":"2443763104","title":"G1 Therapeutics, Inc.盘中异动 急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443763104","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443763104?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:38","pubTimestamp":1718300314,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时38分,G1 Therapeutics, Inc.股票出现异动,股价快速上涨5.14%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。消息层面,截至01时38分,《Needham维持G1 Therapeutics买入评级,维持目标价12美元》资讯为影响G1 Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013835aef4d85b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013835aef4d85b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","LENZ","BK4139"],"gpt_icon":0},{"id":"2439504867","title":"G1 Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439504867","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439504867?lang=zh_cn&edition=full","pubTime":"2024-05-30 02:48","pubTimestamp":1717008510,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日02时48分,G1 Therapeutics, Inc.股票出现波动,股价快速下挫5.00%。截至发稿,该股报3.23美元/股,成交量74.6078万股,换手率1.43%,振幅4.47%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.08%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。该信息摘要如下:HC Wainwright & Co.:重申G1 Therapeutics评级,由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530024830af8af26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530024830af8af26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2439001933","title":"HC Wainwright & Co.:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439001933","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439001933?lang=zh_cn&edition=full","pubTime":"2024-05-29 00:45","pubTimestamp":1716914755,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290046009efac8a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290046009efac8a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GTHX"],"gpt_icon":0},{"id":"2438736306","title":"Needham:重申G1 Therapeutics(GTHX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.","url":"https://stock-news.laohu8.com/highlight/detail?id=2438736306","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438736306?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:03","pubTimestamp":1716908586,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GTHX","BK4139","LENZ"],"gpt_icon":0},{"id":"2438372152","title":"G1 Therapeutics, Inc.盘中异动 急速下跌5.38%报3.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438372152","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438372152?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:36","pubTimestamp":1716903413,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时36分,G1 Therapeutics, Inc.股票出现波动,股价大幅跳水5.38%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.09%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大,Exicure, Inc.、Jaguar Health, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为20.95%、8.10%、7.52%,振幅较大的相关个股有Exicure, Inc.、Corcept医疗、Renovaro Inc.,振幅分别为25.45%、13.15%、12.68%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213653af8ab327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213653af8ab327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2437951182","title":"G1 Therapeutics, Inc.盘中异动 早盘急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437951182","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437951182?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:31","pubTimestamp":1716384712,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时31分,G1 Therapeutics, Inc.股票出现波动,股价快速拉升5.08%。G1 Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Mustang Bio, Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃,换手率分别为183.94%、89.17%、32.34%,振幅较大的相关个股有Rezolute, Inc.、Nutriband Inc C/Wts 、Sol-Gel Technologies Ltd.,振幅分别为13.00%、12.90%、10.55%。G1 Therapeutics, Inc.公司简介:G1 Therapeutics Inc 是一家商业阶段的生物制药公司。其产品COSELA显示有助于保护骨髓免受化疗的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213152af89add4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213152af89add4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2437019266","title":"BUZZ-G1 Therapeutics 因达成放射保护药物许可协议而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2437019266","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437019266?lang=zh_cn&edition=full","pubTime":"2024-05-22 19:31","pubTimestamp":1716377462,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月22日 - ** 癌症疗法开发商 G1 Therapeutics 的股价盘前上涨 4% 至 4.71 美元** G1将与Deimos Biosciences合作 (link),就用于放射保护的药物lerociclib达成全球许可协议,亚太地区除外。 ** 放射保护药物有助于保护健康组织免受放射治疗引起的某些副作用的影响** 除了获得 lerociclib 年累计净销售额 20% 的特许权使用费外,G1 还将获得占 Deimos 已发行股本 10% 的普通股。** 截至上次收盘,GTHX 年累计上涨 48.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4139","LENZ","GTHX"],"gpt_icon":0},{"id":"2437268270","title":"G1 Therapeutics-预计将在全面摊薄的基础上获得占Deimos已发行股本10%的Deimos普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437268270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437268270?lang=zh_cn&edition=full","pubTime":"2024-05-22 18:45","pubTimestamp":1716374732,"startTime":"0","endTime":"0","summary":"G1 Therapeutics-预计将在全面摊薄的基础上获得占Deimos已发行股本10%的Deimos普通股","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052218453587873de4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052218453587873de4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTHX","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.g1therapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":1.8831},{"period":"1year","weight":1.4486},{"period":"ytd","weight":1.3443}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"G1 Therapeutics, Inc.于2008年5月19日以“G-Zero Therapeutics, Inc.”的名义,以特拉华州的法律注册成立。2012年9月,他们更名为“G1治疗公司”。该公司是一家商业化阶段的生物制药公司,专注于开发和商业化治疗癌症患者的新型小分子疗法。美国食品和药物管理局批准的第一个产品COSELA(trilaciclib)是第一个也是唯一一个被证明可以主动帮助保护骨髓免受化疗(骨髓保护)损害的疗法,也是几十年来管理骨髓保护的第一个创新。2022年7月,COSELA(注射用盐酸曲拉西利布)获国家药品监督管理局有条件批准在中国上市。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.163982},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.143278},{"month":3,"riseRate":0.428571,"avgChangeRate":0.000021},{"month":4,"riseRate":0.571429,"avgChangeRate":0.00162},{"month":5,"riseRate":0.428571,"avgChangeRate":0.019708},{"month":6,"riseRate":0.625,"avgChangeRate":0.068331},{"month":7,"riseRate":0.375,"avgChangeRate":0.091503},{"month":8,"riseRate":0.75,"avgChangeRate":0.247961},{"month":9,"riseRate":0.25,"avgChangeRate":-0.102612},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.046198},{"month":11,"riseRate":0.428571,"avgChangeRate":0.013336},{"month":12,"riseRate":0.285714,"avgChangeRate":0.000011}],"exchange":"NASDAQ","name":"G1 Therapeutics Inc.","nameEN":"G1 Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供G1 Therapeutics Inc.(GTHX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"G1 Therapeutics Inc.,GTHX,G1 Therapeutics Inc.股票,G1 Therapeutics Inc.股票老虎,G1 Therapeutics Inc.股票老虎国际,G1 Therapeutics Inc.行情,G1 Therapeutics Inc.股票行情,G1 Therapeutics Inc.股价,G1 Therapeutics Inc.股市,G1 Therapeutics Inc.股票价格,G1 Therapeutics Inc.股票交易,G1 Therapeutics Inc.股票购买,G1 Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供G1 Therapeutics Inc.(GTHX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}